Disagree. They have an extremely valuable niche market, they have seen into the future, they have honed their skills and about to capitilse on it now big time.The market has spoken imho.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025